Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

GVK BIO announces drug discovery pact with Wyeth
June 2008
SHARING OPTIONS:

HYDERABAD, IndiaŚGVK BIO announced last month it entered into a research agreement with Wyeth Pharmaceuticals, a division of Wyeth, to discover drug candidates focused on pre-defined discovery targets. GVK BIO will use in-house capabilities in discovery chemistry, informatics, biology and ADME to advance this program. GVK BIO will be responsible for identifying drug candidates, which will be transferred to Wyeth to advance these compounds toward clinical studies. Under the agreement, GVK BIO will receive an initial payment and will be eligible for success-based milestone payments.

"GVK BIO has had a successful partnership with Wyeth on various chemis try research activities dating to 2006," says Sanjay Reddy, managing director, GVK Biosciences. "This research agreement expands our work together and builds on GVK BIO's core strengths."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.